These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 2650063
21. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival. Grazia TJ, Gill RG, Gelhaus HC, Doan AN, Sleater ML, Pietra BA. J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264 [Abstract] [Full Text] [Related]
22. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice. Cai Y, Tang XD, Zhou PJ. Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744 [Abstract] [Full Text] [Related]
23. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Mottram PL, Han WR, Purcell LJ, McKenzie IF, Hancock WW. Transplantation; 1995 Feb 27; 59(4):559-65. PubMed ID: 7878761 [Abstract] [Full Text] [Related]
24. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice. Lowry RP, Konieczny B, Alexander D, Larsen C, Pearson T, Smith S, Narula S. Transplant Proc; 1995 Feb 27; 27(1):392-4. PubMed ID: 7879034 [No Abstract] [Full Text] [Related]
25. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection. Pelletier R, Ohye R, Kincade P, Ferguson R, Orosz C. Transplant Proc; 1993 Feb 27; 25(1 Pt 1):839-41. PubMed ID: 7679845 [No Abstract] [Full Text] [Related]
26. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies. Isobe M, Suzuki J, Yagita H, Okumura K, Yamazaki S, Nagai R, Yazaki Y, Sekiguchi M. J Immunol; 1994 Dec 15; 153(12):5810-8. PubMed ID: 7527450 [Abstract] [Full Text] [Related]
27. Graft endothelial VCAM-1 is not necessary for acute cardiac allograft rejection in mice. Bergese SD, Pelletier RP, Ferguson RM, Orosz CG. Transplant Proc; 1995 Feb 15; 27(1):480-1. PubMed ID: 7533417 [No Abstract] [Full Text] [Related]
28. Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection. Eto M, Yoshikai Y, Nishimura Y, Hiromatsu K, Maeda T, Nomoto K, Kong YY, Kubo RT, Kumazawa J, Nomoto K. Immunology; 1994 Feb 15; 81(2):198-204. PubMed ID: 8157269 [Abstract] [Full Text] [Related]
29. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation. Pearson TC, Hamano K, Morris PJ, Wood KJ. Transplant Proc; 1993 Feb 15; 25(1 Pt 1):786-7. PubMed ID: 8438480 [No Abstract] [Full Text] [Related]
30. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Guillonneau C, Aubry V, Renaudin K, Séveno C, Usal C, Tezuka K, Anegon I. Transplantation; 2005 Aug 27; 80(4):546-54. PubMed ID: 16220623 [Abstract] [Full Text] [Related]
31. CD4 T cells and allograft rejection. Hao L, Wang Y, Gill RG, Lafferty KJ. Transplant Proc; 1988 Feb 27; 20(1):56-60. PubMed ID: 2449753 [No Abstract] [Full Text] [Related]
32. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy. Orosz CG, Bergese SD, Huang EH, Vanbuskirk AM. Transplant Proc; 1995 Feb 27; 27(1):387-8. PubMed ID: 7533414 [No Abstract] [Full Text] [Related]
33. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression. Knulst AC, Tibbe GJ, Noort WA, Bril-Bazuin C, Benner R, Savelkoul HF. Bone Marrow Transplant; 1994 Mar 27; 13(3):293-301. PubMed ID: 8199571 [Abstract] [Full Text] [Related]
34. Prolongation of murine cardiac allograft survival by the anti-interleukin-2 receptor monoclonal antibody AMT-13. Kirkman RL, Barrett LV, Koltun WA, Diamantstein T. Transplant Proc; 1987 Feb 27; 19(1 Pt 1):618-9. PubMed ID: 3274828 [No Abstract] [Full Text] [Related]
35. CD45RB monoclonal antibody induces tolerance in the mouse kidney graft, but fails to prevent small bowel graft rejection. Zhang Z, Lazarovits A, Grant D, Garcia B, Stiller C, Zhong R. Transplant Proc; 1996 Oct 27; 28(5):2514. PubMed ID: 8907929 [No Abstract] [Full Text] [Related]
36. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies. Stepkowski SM, Tu Y, Condon TP, Bennett CF. Transplant Proc; 1995 Feb 27; 27(1):113. PubMed ID: 7878822 [No Abstract] [Full Text] [Related]
38. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice. Bashuda H, Seino K, Kano M, Sato K, Azuma M, Yagita H, Okumura K. Transplant Proc; 1996 Apr 27; 28(2):1039-41. PubMed ID: 8623220 [No Abstract] [Full Text] [Related]